$AAPL·4

APPLE INC · Jul 31, 6:40 PM ET

APPLE INC 4

4 · APPLE INC · Filed Jul 31, 2012

Insider Transaction Report

Form 4
Period: 2012-07-30
Transactions
  • Exercise/Conversion

    Common Stock

    2012-07-30$7.00/sh+10,000$69,95011,574 total
  • Sale

    Common Stock

    2012-07-30$588.85/sh2,100$1,236,5949,474 total
  • Sale

    Common Stock

    2012-07-30$590.24/sh3,789$2,236,4135,685 total
  • Sale

    Common Stock

    2012-07-30$591.32/sh4,111$2,430,9201,574 total
  • Exercise/Conversion

    Director Stock Option (Right to Buy)

    2012-07-3010,0000 total
    Exercise: $7.00From: 2002-08-05Exp: 2012-08-05Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 1, 2012.
  • [F2]This transaction was executed in multiple trades at prices ranging from $588.67 to $589.29; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F3]This transaction was executed in multiple trades at prices ranging from $589.67 to $590.66; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.
  • [F4]This transaction was executed in multiple trades at prices ranging from $590.69 to $591.46; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT